DAS-28-based EULAR response and HAQ improvement in rheumatoid arthritis patients switching between TNF antagonists
<p>Abstract</p> <p>Introduction</p> <p>No definitive data are available regarding the value of switching to an alternative TNF antagonist in rheumatoid arthritis patients who fail to respond to the first one. The aim of this study was to evaluate treatment response in a...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-07-01
|
Series: | BMC Musculoskeletal Disorders |
Online Access: | http://www.biomedcentral.com/1471-2474/10/91 |